&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-12-08, 16:00

Geneva College of Longevity Science and DrVibe.ai Launch the GCLS AI Academy for Longevity Sciences
Jamal Emanuel

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-09-03, 00:34

Zoom wins Engineering, Science & Technology Emmy® Award for innovation in broadcast contribution
Bud Eliott

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-11-13, 17:43

EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024
Etsuko Liu

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-18, 22:15

Global Virus Network’s Annual Meeting Fortifies Bonds on the African Continent to Catalyze Innovative Research, Strengthen Pandemic Preparedness, and Combat Scientific Misinformation
Lino McAdams

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-02, 11:47

CORRECTION: The Global Virus Network (GVN) Escalates MPOX Emergency Response Across Africa and Beyond
Caridad Becker

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-01, 00:51

CORRECTION: The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-29, 22:48

The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners
Tony Loman

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-16, 20:46

The Global Virus Network (GVN) Escalates MPOX Emergency Response Across Africa and Beyond
Cassie Shields

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-04-15, 19:00

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-04-15, 19:00

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

Notified -

Popular Posts